182
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines

, , &
Pages 263-275 | Received 06 Oct 2020, Accepted 08 Mar 2021, Published online: 25 Mar 2021

References

  • Allen, T.M., and Cullis, P.R., 2013. Liposomal drug delivery systems: from concept to clinical applications. Advanced drug delivery reviews, 65 (1), 36–48.
  • Bansal, S., et al., 2012. A comparative review on vesicular drug delivery system and stability issues. International journal of research in pharmacy and chemistry, 2, 704–713.
  • Basniwal, R.K., et al., 2011. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. Journal of agricultural and food chemistry, 59, 2056–2061.
  • Basniwal, R.K., Khosla, R., and Jain, N., 2014. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water. Nutrition and cancer, 66 (6), 1015–1022.
  • Bhawana, B.R., et al., 2011. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. Journal of agricultural and food chemistry, 59, 2056–2061.
  • Bisht, S., et al., 2007. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Journal of nanobiotechnology, 5, 3.
  • Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68 (6), 394–424.
  • Bron, R., et al., 1993. [23] Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes). Methods in enzymology, 220, 313–331.
  • Bron, R., Ortiz, A., and Wilschut, J., 1994. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes). Biochemistry, 33 (31), 9110–9117.
  • Chen, Y., and Liu, L., 2012. Modern methods for delivery of drugs across the blood-brain barrier. Advanced drug delivery reviews, 64 (7), 640–665.
  • Cory, G., 2011. Scratch-wound assay. In: Cell migration. Humana Press, 25–30.
  • Cronin, K.A., et al., 2018. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer, 124 (13), 2785–2800.
  • DE Jonge, J., et al., 2006. Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes. Biochimica et biophysica acta (bba) - biomembranes, 1758 (4), 527–536.
  • DE Oliveira, C., et al., 2018. Enhanced and selective antiproliferative activity of Methotrexate-Functionalized-Nanocapsules to human breast cancer cells (MCF-7). Nanomaterials, 8 (1), 24.
  • Ehrnst, A., et al., 1988. Efficient isolation of HIV from plasma during different stages of HIV infection. Journal of medical virology, 26 (1), 23–32.
  • Felnerova, D., et al., 2004. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Current opinion in biotechnology, 15 (6), 518–529.
  • Flora, G., Gupta, D., and Tiwari, A., 2013. Nanocurcumin: a promising therapeutic advancement over native curcumin. Critical reviews™ in therapeutic drug carrier systems, 30 (4), 331–368.
  • Kaneda, Y., 2000. Virosomes: evolution of the liposome as a targeted drug delivery system. Advanced drug delivery reviews, 43 (2-3), 197–205.
  • Kobayashi, M., et al., 2012. A proposed protocol for the standardized preparation of PRF membranes for clinical use. Biologicals: journal of the international association of biological standardization, 40 (5), 323–329.
  • Kumar, V., Kumar, R., and Jain, V., 2020. Preparation and characterization of influenza virosomes using nonionic, dialyazble phospholipid for efficient membrane solubilization and reconstitution. In: Recent trends in materials and devices. Singapore: Springer, 221–231.
  • Kumar, V., et al., 2021. Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity. Scientific reports, 11 (1), 1–14.
  • Kumaran, A., and Joel Karunakaran, R., 2006. Antioxidant and free radical scavenging activity of an aqueous extract of Coleus aromaticus. Food chemistry, 97 (1), 109–114.
  • Li, Z., et al., 2020. Novel folated pluronic F127 modified liposomes for delivery of curcumin: preparation, release, and cytotoxicity. Journal of microencapsulation, 37 (3), 220–229.
  • Liu, H., et al., 2015. Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment. Acta pharmaceutica (zagreb, Croatia), 65 (2), 105–116.
  • Moore, P.D., Yedjou, C.G., and Tchounwou, P.B., 2010. Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cells. Environmental toxicology, 25 (3), 221–226.
  • Mukherjee, S., Ray, S., and Thakur, R., 2009. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian journal of pharmaceutical sciences, 71 (4), 349–358.
  • Müller, R.H., and Keck, C.M., 2004. Drug delivery to the brain-realization by novel drug carriers. Journal of nanoscience and nanotechnology, 4 (5), 471–483.
  • Ng, Z.Y., et al., 2018. Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma. Colloids and surfaces B: Biointerfaces, 172, 51–59.
  • Oliveira, A.R., et al., 2015. HPLC-DAD and UV-Vis spectrophotometric methods for methotrexate assay in different biodegradable microparticles. Journal of the brazilian chemical society, 26, 649–659.
  • Oskoueian, E., et al., 2020. Nanoliposomes encapsulation of enriched phenolic fraction from pistachio hulls and its antioxidant, anti-inflammatory, and anti-melanogenic activities. Journal of microencapsulation, 37 (1), 1–13.
  • Panda, S.K., Ravindran, B., and Histopaque, F., 2013. Isolation of human PBMCs. BIO-PROTOCOL, 3 (3), e323.
  • Parhizkar, E., Emadi, L., and Alipour, S., 2017. Development and evaluation of midazolam in situ nasal gel properties in presence of solubility enhancers at cilia-friendly pH. Macromolecular research, 25 (3), 255–261.
  • Parhizkar, E., et al., 2018. Design and development of vitamin C-encapsulated proliposome with improved in-vitro and ex-vivo antioxidant efficacy. Journal of microencapsulation, 35 (3), 301–311.
  • Rodriguez, L. G., Wu, X., and Guan, J.-L., 2005. Wound-healing assay. In: Cell migration. Humana Press, 23–29.
  • Sambuy, Y., et al., 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell biology and toxicology, 21 (1), 1–26.
  • Scheule, R.K., 1986. Novel preparation of functional Sindbis virosomes. Biochemistry, 25 (15), 4223–4232.
  • Shimatsu, A., et al., 2012. Clinical application of “curcumin”, a multi-functional substance. Anti-Aging med, 9, 75–83.
  • Singh, M., et al., 2019. Delivery of phytochemicals by liposome cargos: recent progress, challenges and opportunities. Journal of microencapsulation, 36 (3), 215–235.
  • Singh, R., and Lillard Jr, J.W., 2009. Nanoparticle-based targeted drug delivery. Experimental and molecular pathology, 86 (3), 215–223.
  • Stegmann, T., et al., 1987. Functional reconstitution of influenza virus envelopes. The EMBO journal, 6 (9), 2651–2659.
  • Stoddart, M. J., 2011a. Cell viability assays: introduction. In: Mammalian cell viability. Springer, 1–6.
  • Stoddart, M. J., 2011b. Mammalian cell viability: methods and protocols. Humana Press, 1–19.
  • Storka, A., et al., 2015. Safety, tolerability and pharmacokinetics of liposomal curcumin (Lipocurc™) in healthy humans. Int. Journal of clinical pharmacology and therapeutics, 53 (01), 54–65.
  • Suman , Kumar, V., Kumar, V. & Jain, V. K. 2018. Preparation and characterization of nanocurcumin encapsulated virosome for cancer treatment. India patent application 201711001264.
  • Vakifahmetoglu, H., Olsson, M., and Zhivotovsky, B., 2008. Death through a tragedy: mitotic catastrophe. Cell death and differentiation, 15 (7), 1153–1162.
  • Wang, S., et al., 2011. Nanotechnologies for curcumin: an ancient puzzler meets modern solutions. Journal of nanomaterials, 2011, 8.
  • Wilkening, S., Stahl, F., and Bader, A., 2003. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug metabolism and disposition: the biological fate of chemicals, 31 (8), 1035–1042.
  • Yarrow, J.C., et al., 2004. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC biotechnology, 4, 21.
  • Yen, G.-C., Lai, H.-H., and Chou, H.-Y., 2001. Nitric oxide-scavenging and antioxidant effects of Uraria crinita root. Food chemistry, 74 (4), 471–478.
  • Zhang, Y., et al., 2004. Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis. Acta pharmacologica sinica, 25 (1), 83–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.